chr22-32801732-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_000362.5(TIMP3):​c.-270G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 215,944 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 0 hom. )

Consequence

TIMP3
NM_000362.5 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.413

Publications

1 publications found
Variant links:
Genes affected
TIMP3 (HGNC:11822): (TIMP metallopeptidase inhibitor 3) This gene belongs to the TIMP gene family. The proteins encoded by this gene family are inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix (ECM). Expression of this gene is induced in response to mitogenic stimulation and this netrin domain-containing protein is localized to the ECM. Mutations in this gene have been associated with the autosomal dominant disorder Sorsby's fundus dystrophy. [provided by RefSeq, Jul 2008]
SYN3 (HGNC:11496): (synapsin III) This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. The protein encoded by this gene shares the synapsin family domain model, with domains A, C, and E exhibiting the highest degree of conservation. The protein contains a unique domain J, located between domains C and E. Based on this gene's localization to 22q12.3, a possible schizophrenia susceptibility locus, and the established neurobiological roles of the synapsins, this family member may represent a candidate gene for schizophrenia. The TIMP3 gene is located within an intron of this gene and is transcribed in the opposite direction. Alternative splicing of this gene results in multiple splice variants that encode different isoforms. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00166 (253/152182) while in subpopulation NFE AF = 0.00312 (212/67958). AF 95% confidence interval is 0.00278. There are 1 homozygotes in GnomAd4. There are 120 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 253 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TIMP3NM_000362.5 linkc.-270G>T 5_prime_UTR_variant Exon 1 of 5 ENST00000266085.7 NP_000353.1 P35625
SYN3NM_003490.4 linkc.711+63183C>A intron_variant Intron 6 of 13 ENST00000358763.7 NP_003481.3 O14994A0A024R1I8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TIMP3ENST00000266085.7 linkc.-270G>T 5_prime_UTR_variant Exon 1 of 5 1 NM_000362.5 ENSP00000266085.5 P35625
SYN3ENST00000358763.7 linkc.711+63183C>A intron_variant Intron 6 of 13 5 NM_003490.4 ENSP00000351614.2 O14994
SYN3ENST00000462268.1 linkn.225+63183C>A intron_variant Intron 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.00166
AC:
253
AN:
152074
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00312
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00282
AC:
180
AN:
63762
Hom.:
0
Cov.:
3
AF XY:
0.00292
AC XY:
97
AN XY:
33206
show subpopulations
African (AFR)
AF:
0.000597
AC:
1
AN:
1676
American (AMR)
AF:
0.000669
AC:
1
AN:
1494
Ashkenazi Jewish (ASJ)
AF:
0.000547
AC:
1
AN:
1828
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3456
South Asian (SAS)
AF:
0.00
AC:
0
AN:
766
European-Finnish (FIN)
AF:
0.00190
AC:
10
AN:
5252
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
348
European-Non Finnish (NFE)
AF:
0.00350
AC:
158
AN:
45086
Other (OTH)
AF:
0.00233
AC:
9
AN:
3856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00166
AC:
253
AN:
152182
Hom.:
1
Cov.:
32
AF XY:
0.00161
AC XY:
120
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41572
American (AMR)
AF:
0.000196
AC:
3
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00312
AC:
212
AN:
67958
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000425
Hom.:
0
Bravo
AF:
0.00173

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Sorsby fundus dystrophy Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.4
DANN
Benign
0.65
PhyloP100
0.41
PromoterAI
-0.028
Neutral
Mutation Taster
=278/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs532843825; hg19: chr22-33197718; API